ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

GE Venture To Design Novel Vaccines Plant

by Michael McCoy
April 15, 2013 | APPEARED IN VOLUME 91, ISSUE 15

[+]Enlarge
Credit: PRNewsFoto/iBio
iBio grows pharmaceutical proteins in green plants.
09115-buscon-NY91038cxd.jpg
Credit: PRNewsFoto/iBio
iBio grows pharmaceutical proteins in green plants.

A seven-month-old alliance between GE Healthcare and the biologics production specialist iBio has won a contract to design a plant-based vaccines facility in Brazil for the country’s Ministry of Health. iBio says its gene-expression technology causes nontransgenic plants to rapidly produce high levels of target proteins. The technique manufactures biologic drugs faster and less expensively than do cell-culture-based methods, the firm claims.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment